Sudeep Pharma IPO open date is November 21, 2025, and the closing date is November 25, 2025. This new IPO is a book-built issue of 1,50,92,750 equity shares aggregating up to Rs 895 crore. This upcoming IPO consists of a fresh issue of 16,02,024 equity shares aggregating up to Rs 95 crore and an offer for sale of 1,34,90,726 equity shares aggregating up to Rs 800 crore.
Sudeep Pharma IPO price band is Rs 563 to Rs 593 per share. As of November 18, 2025, the Sudeep Pharma IPO GMP Live quotation is at Rs 30 (5.06%). Live IPO Grey Market Premium details will be available online. The Sudeep Pharma IPO DRHP has been filed with SEBI on June 24, 2025.
Sudeep Pharma IPO allotment status will be available on November 26, 2025. Sudeep Pharma IPO lot size is 25 shares. The minimum investment for retail investors for 1 lot is Rs 14,825. The registrar for the Sudeep Pharma IPO is MUFG Intime India Pvt. Ltd. Sudeep Pharma IPO listing date is November 28, 2025.
Also Read | Excelsoft Technologies IPO GMP, Open Date, Price Band
Sudeep Pharma IPO GMP
Sudeep Pharma IPO GMP is Rs 30 (5.06%) per share as on November 18, 2025. The IPO GMP today indicates a neutral sentiment among retail investors. You can check the latest IPO Grey Market Premium online from the first day of subscription. If the subscription is oversubscribed, then Sudeep Pharma IPO GMP might improve.
Sudeep Pharma IPO: Listing Date, Lot Size, Price Band
|
IPO Date |
November 21, 2025 to November 25, 2025 |
|
Listing Date |
November 28, 2025 |
|
Face Value |
Re 1 per share |
|
Issue Price Band |
Rs 563 to Rs 593 per share |
|
Lot Size |
25 Shares |
|
Total Issue Size |
1,50,92,750 shares (aggregating up to Rs 895.00 Cr) |
|
Offer for Sale |
1,34,90,726 shares (aggregating up to Rs 800.00 Cr) |
|
Fresh Issue |
16,02,024 shares (aggregating up to Rs 95.00 Cr) |
|
Issue Type |
Bookbuilding IPO |
|
Listing At |
BSE, NSE |
|
Shareholding Pre-Issue |
11,13,46,602 shares |
|
Shareholding Post-Issue |
11,29,48,626 shares |
Sudeep Pharma IPO Open Date, Close Date
Sudeep Pharma IPO open date is November 21, 2025, and the IPO close date is November 25, 2025. The initiation of the refund date is November 27, 2025, and the credit of shares will be on November 27, 2025.
Sudeep Pharma IPO: Key Dates, Allotment, Listing Date
|
IPO Open Date |
November 21, 2025 |
|
IPO Close Date |
November 25, 2025 |
|
Basis of Allotment |
November 26, 2025 |
|
Initiation of Refunds |
November 27, 2025 |
|
Credit of Shares to Demat |
November 27, 2025 |
|
Listing Date |
November 28, 2025 |
|
Cut-off time for UPI mandate |
5 PM November 25, 2025 |
Sudeep Pharma IPO Price Band
Sudeep Pharma IPO price band is Rs 563 to Rs 593 per share. The minimum amount of investment for the retail category is Rs 14,825, and for small HNI, the minimum investment is Rs 2,07,550. The minimum investment for the Big HNI is Rs 10,08,100.
Sudeep Pharma IPO Issue Size
Sudeep Pharma IPO is a book-built issue of 1,50,92,750 equity shares aggregating up to Rs 895 crore. The issue comprises a fresh issue of 16,02,024 equity shares aggregating up to Rs 95 crore and an offer for sale of 1,34,90,726 equity shares aggregating up to Rs 800 crore.
Sudeep Pharma IPO Allotment Status
Sudeep Pharma IPO allotment status will be available on November 26, 2025. The listing will be on the BSE and NSE platforms. The registrar of this IPO is MUFG Intime India Pvt. Ltd. Investors can check their allotment status after the subscription ends.
Sudeep Pharma IPO Listing Date
Sudeep Pharma IPO listing date is November 28, 2025. The listing will be on the BSE and NSE platforms. Retail investors can sell the shares after 10 AM on the listing day.
Sudeep Pharma Limited: About the Company

Sudeep Pharma Limited, established in 1989, specializes in the development and manufacturing of pharmaceutical excipients, mineral actives, and specialty nutrition ingredients for the global market. Operating six manufacturing facilities with advanced automation and an annual capacity surpassing 70,000 metric tons, the company delivers over 200 products serving pharmaceutical, food, and nutrition industries across more than 100 countries. Their USFDA-certified plants produce a range of mineral-based ingredients such as calcium, iron, magnesium, zinc, potassium, and sodium, used in tablets, capsules, food fortification, and dietary supplements. Sudeep Pharma emphasizes innovation via a robust R&D division focused on particle engineering, enhanced nutrient bioavailability, and sustainable formulation solutions. With international offices and certifications like EXCiPACT, BRC, and ISO, Sudeep Pharma is recognized for its quality-driven exports and long-standing global customer relationships.
Sudeep Pharma IPO Objectives
Sudeep Pharma Ltd. proposes to utilize the net proceeds from the issue towards capital expenditure for procuring machinery for the production line at its Nandesari Facility I, as well as for general corporate purposes.
Sudeep Pharma Financials (Amt in Rs Cr)
|
Period Ended |
30 Jun 2025 |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
Assets |
922.26 |
717.17 |
513.87 |
420.11 |
|
Total Income |
130.08 |
511.33 |
465.38 |
438.26 |
|
Profit After Tax |
31.27 |
138.69 |
133.15 |
62.32 |
|
EBITDA |
48.57 |
199.28 |
187.76 |
98.64 |
|
Net Worth |
688.32 |
497.53 |
359.07 |
226.29 |
|
Reserves and Surplus |
668.52 |
481.11 |
354.59 |
221.88 |
|
Total Borrowing |
135.97 |
135.25 |
75.03 |
82.26 |
Sudeep Pharma IPO Promoter Holdings
The promoters of Sudeep Pharma Limited are Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani HUF, Riva Resources Private Limited, and Bhayani Family Trust. The promoter shareholding before the IPO was 89.37%; after the IPO, the promoter shareholding will be 76.15%.
Sudeep Pharma IPO Registrar
Sudeep Pharma IPO registrar is MUFG Intime India Pvt. Ltd.
Investors can check their allotment status on the registrar’s website using their PAN or application number.
How to Apply to the Sudeep Pharma IPO
Investors can apply to the Sudeep Pharma IPO through the Bigul trading app by clicking here.
They can also check details of other upcoming IPOs on Bigul.
Sudeep Pharma IPO FAQ
1. What are the details of the Sudeep Pharma IPO?
Sudeep Pharma IPO is a book-built issue of 1,50,92,750 equity shares aggregating up to Rs 895 crore. The issue includes a fresh issue of Rs 95 crore and an offer for sale of Rs 800 crore.
2. When will the Sudeep Pharma IPO open and close?
The IPO opens on November 21, 2025, and closes on November 25, 2025. Refunds begin on November 27, 2025, and shares are credited on the same day.
3. What is Sudeep Pharma IPO GMP?
The Sudeep Pharma IPO GMP is Rs 30 (5.06%) per share as on November 18, 2025.
4. What is the Sudeep Pharma IPO allotment date?
The Sudeep Pharma IPO allotment will be declared on November 26, 2025.
5. Who is the registrar and lead manager for the Sudeep Pharma IPO?
The registrar is MUFG Intime India Pvt. Ltd. Lead managers are ICICI Securities Ltd. and IIFL Capital Services Ltd.
Also Read | Tenneco Clean Air India IPO GMP, Open Date, Price Band, Issue Size